EU regulator begins real-time review of first Chinese COVID-19 vaccine

Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus. Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential approvals, the European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/ema-starts-rolling-review-covid-19-vaccine-vero-cell-inactivated.

Reuters | London | Updated: 04-05-2021 16:14 IST | Created: 04-05-2021 15:24 IST
EU regulator begins real-time review of first Chinese COVID-19 vaccine
Representative Image Image Credit: ANI

Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's COVID-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.

Data on the vaccine, COVID-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed up potential approvals, the European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/ema-starts-rolling-review-covid-19-vaccine-vero-cell-inactivated. This is the first Chinese vaccine the EMA is studying in real-time, and the fourth COVID-19 vaccine under such a review, including those from CureVac, Novavax Inc and Russia's Sputnik V.

Sinovac's vaccine has shown efficacy rates between 50% and 90% in different studies and is currently authorised for use in China, Indonesia, Brazil and Turkey. The vaccine contains inactivated or dead versions of the SARS-CoV-2 virus to help the human body's immune system make antibodies.

In early April, Sinovac said its third production plant for its vaccine, branded CoronaVac in some regions, was ready, doubling its annual capacity to 2 billion doses. The firm said more than 200 million doses of Sinovac's vaccine have been delivered globally. Rolling reviews are aimed at speeding up the approval process by allowing researchers to submit findings in real-time before final trial data is available.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

After facing criticism, Hong Kong govt says freezing of Jimmy Lai's assets has nothing to do with press freedom

The freezing of HKD 500 million of Jimmy Lais assets has nothing to do with press freedom, claimed Hong Kong administration after the city journalists association chided the latest action against the jailed media tycoon.The Hong Kong Stock ...

Cyclone: Winds, rain partially damage 190 structures in Pune

Gusty winds coupled with rains caused by very severe cyclonic storm Tauktae led to collpase of roofs of houses and uprooting of utility poles in Pune district of Maharashtra on Monday, officials said.Three people sustained minor injuries, t...

Eurovision song contest prepares for slimmed down COVID version

The Dutch port city of Rotterdam is preparing for a slimmed down version of the Eurovision song contest this weekend with a limited live audience, amid falling but still significant COVID-19 infection rates in the Netherlands. When we made ...

France's Macron says to work with Jordan, Egypt leaders on Israel/Gaza ceasefire, talks

Frances president said on Monday he would in the coming days work with Egypts president and Jordans king on a concrete proposal for a ceasefire and a possible path to discussions between Israel and the Palestinians.Speaking at a news confer...

Give Feedback